A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery

CompletedOBSERVATIONAL
Enrollment

979

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Meningioma
Interventions
DRUG

prophylactic enoxaparin

enoxaparin had been prescribed at a dose of 40 mg (once daily) from the evening before surgery until patients were well mobilized. Also, at the time of surgery compression stockings were used, as well as a sequential compression device (SCD) until the morning after or longer if mobilization was delayed

PROCEDURE

non-prophylactic

no pharmacological prophylaxis for venous thromboembolism (VTE) had been used routinely. Occasionally, with delayed mobilization, a low-dose low molecular weight heparin (LMWH) had been prescribed. SCD had been used at increased frequency, and is today considered routine.

Trial Locations (3)

Unknown

University Hospital of North Norway, Tromsø

St Olavs Hospital, Trondheim

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

Karolinska University Hospital

OTHER

lead

St. Olavs Hospital

OTHER

NCT01941602 - A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery | Biotech Hunter | Biotech Hunter